Status:
TERMINATED
Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA)
Lead Sponsor:
University Hospital, Caen
Conditions:
Kidney Failure, Acute
Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
Associations between angiotensin-converting enzyme gene polymorphism and occurrence and outcome of ARDS, and with respiratory complications post cardiopulmonary bypass have already been demonstrated. ...
Detailed Description
Associations between angiotensin-converting enzyme gene polymorphism and occurrence and outcome of ARDS, and with respiratory complications post cardiopulmonary bypass have already been demonstrated. ...
Eligibility Criteria
Inclusion
- Age \> 18 yrs
- ICU stay \> 48 hours
Exclusion
- Age \< 18 yrs
- Creatinine \> 180 µmol/L
- Absence of consent
Key Trial Info
Start Date :
May 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2006
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00316576
Start Date
May 1 2006
End Date
November 1 2006
Last Update
January 17 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Intensive care Unit; Caen University Hospital
Caen, France, 14000